Financials
- Market Capitalization 328.31 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.36
売上高対価格比率
2.41
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3209 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.72 USD | 0.00% | -1.06% | -3.63% | +71.43% | 338.47 M USD | ||
| 3223 | STRO Sutro Biopharma, Inc. - Common Stock | 20.07 USD | -2.29% | +2.29% | -22.24% | +15.41% | 332.78 M USD | ||
| 3248 | SION Sionna Therapeutics, Inc. - Common Stock | 7.18 USD | +6.37% | +22.32% | -85.88% | -81.75% | 324.63 M USD | ||
| 3249 | PYXS Pyxis Oncology, Inc. - Common Stock | 3.89 USD | +8.96% | +21.56% | +2.91% | +96.46% | 324.46 M USD |